AMWL - American Well Corporation
NYSE
->
Healthcare
->
Health Information Services
Boston,
United States
Type: Equity
AMWL price evolution
AMWL
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $277.7 | $309.39 | $372.83 | |
| Short term investments | ||||
| Net receivables | $89.26 | $76.09 | $80.71 | $54.15 |
| Inventory | $4.76 | $5.57 | $6.58 | $6.65 |
| Total current assets | $356.88 | $378.17 | $414.2 | $449.58 |
| Long term investments | $1.2 | $1.97 | $1.18 | |
| Property, plant & equipment | $8.44 | $9.3 | $10.18 | $11.03 |
| Goodwill & intangible assets | $111.22 | $114.34 | $120.25 | |
| Total noncurrent assets | $129.65 | $134.19 | $140.12 | |
| Total investments | $1.2 | $1.97 | $1.18 | |
| Total assets | $482.99 | $507.82 | $548.38 | $589.71 |
| Current liabilities | ||||
| Accounts payable | $8.15 | $5.92 | $6.71 | $4.86 |
| Deferred revenue | $68.55 | $66.97 | $52.46 | |
| Short long term debt | $3.63 | $3.6 | $3.58 | |
| Total current liabilities | $122.17 | $117.9 | $108.43 | $93.8 |
| Long term debt | $6.36 | $7.29 | $8.21 | |
| Total noncurrent liabilities | $12.05 | $16.6 | $15.72 | |
| Total debt | $9.99 | $10.89 | $11.79 | |
| Total liabilities | $146.32 | $129.95 | $125.03 | $109.52 |
| Shareholders' equity | ||||
| Retained earnings | -$1923.27 | -$1879.8 | -$1829.88 | -$1757.78 |
| Other shareholder equity | -$15.77 | -$20.96 | -$16.21 | -$15.65 |
| Total shareholder equity | $363.9 | $408.74 | $464.22 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $372.83 | $539.34 | $747.21 | $942.71 |
| Short term investments | $99.96 | |||
| Net receivables | $54.15 | $58.37 | $51.38 | $45.3 |
| Inventory | $6.65 | $8.74 | $7.53 | $9.13 |
| Total current assets | $449.58 | $626.62 | $827.3 | $1113.29 |
| Long term investments | $1.18 | $0.17 | $0.75 | |
| Property, plant & equipment | $11.03 | $14.52 | $18.66 | $10.45 |
| Goodwill & intangible assets | $120.25 | $570.26 | $595.17 | $249.41 |
| Total noncurrent assets | $140.12 | $590.94 | $618.54 | $263.36 |
| Total investments | $1.18 | $0.17 | $100.72 | |
| Total assets | $589.71 | $1217.56 | $1445.84 | $1376.65 |
| Current liabilities | ||||
| Accounts payable | $4.86 | $7.24 | $12.16 | $5.8 |
| Deferred revenue | $52.46 | $55.79 | $75.9 | $74.8 |
| Short long term debt | $3.58 | $3.06 | $1.92 | $6.36 |
| Total current liabilities | $93.8 | $114.06 | $141.63 | $120.98 |
| Long term debt | $8.21 | $11.79 | $14.69 | $1.3 |
| Total noncurrent liabilities | $15.72 | $19.65 | $43.34 | $9.47 |
| Total debt | $11.79 | $14.84 | $16.61 | $7.65 |
| Total liabilities | $109.52 | $153.68 | $184.96 | $130.45 |
| Shareholders' equity | ||||
| Retained earnings | -$1757.78 | -$1082.03 | -$811.28 | -$582.36 |
| Other shareholder equity | -$15.65 | -$16.97 | -$6.35 | $0.3 |
| Total shareholder equity | $464.22 | $1063.88 | $1239.26 | $1224.13 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $61.05 | $62.79 | $59.52 | $70.68 |
| Cost of revenue | $39.29 | $41.15 | $46.83 | |
| Gross Profit | $22.69 | $23.5 | $18.37 | $23.84 |
| Operating activities | ||||
| Research & development | $20.81 | $26.68 | $26.35 | |
| Selling, general & administrative | $46.85 | $58.48 | $46.19 | |
| Total operating expenses | $70.06 | $75.87 | $93.4 | $80.8 |
| Operating income | -$52.38 | -$75.03 | -$56.95 | |
| Income from continuing operations | ||||
| EBIT | -$49.82 | -$70.83 | -$48.04 | |
| Income tax expense | -$0.15 | $0.1 | $1.27 | $0.55 |
| Interest expense | $3.88 | |||
| Net income | ||||
| Net income | -$43.46 | -$49.92 | -$72.11 | -$48.59 |
| Income (for common shares) | -$49.92 | -$72.11 | -$48.59 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $259.05 | $277.19 | $252.79 | $245.26 |
| Cost of revenue | $164.29 | $160.42 | $148.47 | $156.79 |
| Gross Profit | $94.76 | $116.77 | $104.31 | $88.47 |
| Operating activities | ||||
| Research & development | $105.83 | $138.49 | $106.59 | $84.41 |
| Selling, general & administrative | $213.1 | $227.98 | $160.78 | $221.34 |
| Total operating expenses | $786.9 | $392.62 | $283.46 | $315.91 |
| Operating income | -$692.14 | -$275.85 | -$179.15 | -$227.43 |
| Income from continuing operations | ||||
| EBIT | -$671.3 | -$270.37 | -$181.71 | -$223.79 |
| Income tax expense | $3.86 | $0.06 | -$5.38 | $0.64 |
| Interest expense | ||||
| Net income | ||||
| Net income | -$675.16 | -$270.43 | -$176.33 | -$224.43 |
| Income (for common shares) | -$675.16 | -$270.43 | -$176.33 | -$224.43 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$49.92 | -$72.11 | -$48.59 | |
| Operating activities | ||||
| Depreciation | $8.21 | $8.24 | $8.3 | |
| Business acquisitions & disposals | -$1.72 | |||
| Stock-based compensation | $9.82 | $16.24 | $12.68 | |
| Total cash flows from operations | -$21.79 | -$59.76 | -$41.58 | |
| Investing activities | ||||
| Capital expenditures | -$5.18 | -$2.89 | -$1.32 | |
| Investments | $95.66 | |||
| Total cash flows from investing | -$14.52 | -$5.18 | -$4.61 | $94.34 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.96 | |||
| Net borrowings | ||||
| Total cash flows from financing | $1.38 | $0.96 | ||
| Effect of exchange rate | -$0.35 | -$4.72 | -$0.03 | -$0.1 |
| Change in cash and equivalents | -$127.39 | -$31.69 | -$63.44 | $52.66 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$675.16 | -$270.43 | -$176.33 | -$224.43 |
| Operating activities | ||||
| Depreciation | $31.51 | $26.17 | $16.09 | $10.15 |
| Business acquisitions & disposals | -$3.92 | -$1.96 | -$159.07 | -$2.94 |
| Stock-based compensation | $72.25 | $67.67 | $43.81 | $118.36 |
| Total cash flows from operations | -$148.34 | -$192.32 | -$141.54 | -$112.46 |
| Investing activities | ||||
| Capital expenditures | -$15.25 | -$10.45 | -$0.56 | -$3.32 |
| Investments | $0.78 | $100 | -$60.5 | |
| Total cash flows from investing | -$19.17 | -$11.63 | -$59.63 | -$66.76 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $2.15 | $7.88 | $7.37 | $840.39 |
| Net borrowings | ||||
| Total cash flows from financing | $2.15 | -$3.61 | $5.75 | $983.12 |
| Effect of exchange rate | -$1.14 | -$0.3 | -$0.08 | |
| Change in cash and equivalents | -$166.51 | -$207.87 | -$195.5 | $803.89 |
News
Fundamentals
| Market cap | $110.38M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 15.29M |
| Revenue | $254.03M |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$214.08M |
| Revenue Q/Q | -1.41% |
| Revenue Y/Y | -5.07% |
| P/E ratio | -0.52 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 0.43 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | -$14.00 |
|---|---|
| ROA | -40.22% |
| ROE | N/A |
| Debt/Equity | 0.24 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.92 |
| Quick ratio | 2.88 |